Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Sharps Technology Inc. Warrant (STSSW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/04/2025: STSSW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -72.66% | Avg. Invested days 25 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/04/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.92 | 52 Weeks Range 0.01 - 0.14 | Updated Date 05/24/2025 |
52 Weeks Range 0.01 - 0.14 | Updated Date 05/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.96 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -42.67% | Return on Equity (TTM) -75.14% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 1017855 |
Shares Outstanding - | Shares Floating 1017855 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Sharps Technology Inc. Warrant
Company Overview
History and Background
Sharps Technology, Inc. focuses on developing and manufacturing innovative medical devices, including prefilled syringes and other safety injection products. Founded to address the need for safer injection practices, the company aims to reduce needlestick injuries and improve patient outcomes. Information about the warrant specifically is limited as it's a derivative of the stock.
Core Business Areas
- Medical Device Manufacturing: Sharps Technology develops and manufactures disposable medical devices, including prefilled syringes, syringes with safety features, and custom injection devices.
Leadership and Structure
Information on the leadership team specific to the warrants is limited, but it's related to the overall Sharps Technology Inc. leadership.
Top Products and Market Share
Key Offerings
- Prefilled Syringes: Sharps Technology focuses on prefilled syringes with safety features to minimize needlestick injuries. Market share data for the warrant itself isn't applicable as it's a derivative financial instrument. Competitors: Becton Dickinson (BDX), Medtronic (MDT), Gerresheimer (GRRMF).
Market Dynamics
Industry Overview
The medical device industry is driven by technological advancements, regulatory requirements, and the increasing demand for safer and more efficient healthcare solutions. Safety syringes are gaining traction due to concerns about healthcare worker safety and disease transmission.
Positioning
Sharps Technology aims to differentiate itself through innovative safety features and specialized prefilled syringe solutions. Their position is in a niche market requiring safety and customized solutions.
Total Addressable Market (TAM)
The global prefilled syringes market is expected to reach billions of dollars. Sharps Technology is positioned to capture a share of this market through its specialized offerings.
Upturn SWOT Analysis
Strengths
- Innovative safety features
- Specialized prefilled syringe solutions
- Strong focus on needlestick injury prevention
Weaknesses
- Relatively small market presence compared to larger competitors
- Dependence on specific niche markets
Opportunities
- Increasing demand for safety syringes
- Expansion into new geographic markets
- Partnerships with pharmaceutical companies
Threats
- Competition from larger, established medical device manufacturers
- Regulatory changes affecting medical device approvals
- Pricing pressures from healthcare providers
Competitors and Market Share
Key Competitors
- BDX
- MDT
- GRRMF
Competitive Landscape
Sharps Technology competes with larger medical device manufacturers. Its competitive advantage lies in its focus on safety and specialized solutions, but it faces challenges in terms of market reach and resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is dependent on the overall performance of Sharps Technology Inc.
Future Projections: Future projections depend on factors such as market adoption of safety syringes and successful commercialization of new products.
Recent Initiatives: Recent initiatives might include partnerships, new product development, and expansion into new markets.
Summary
Sharps Technology Inc. warrants' value is tied directly to the underlying SHSP stock. The company focuses on innovative safety features in prefilled syringes and custom injection devices. The company is positioned within a growing niche in the medical device market, but faces stiff competition from larger players. Their growth depends on market adoption and successful partnerships.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (SHSP), Industry reports, Market research
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on thorough research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Sharps Technology Inc. Warrant
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 2022-04-14 | CEO & Director Mr. Robert M. Hayes | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 55 | Website https://sharpstechnology.com |
Full time employees 55 | Website https://sharpstechnology.com | ||
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.